Epstein-Barr virus (EBV) vaccine
Jump to navigation
Jump to search
Comparative biology
- nanoparticle vaccine prevents EBV infection in mice & nonhuman primates
- antibodies block binding of EBV to epithelial cells & B cells
- nanoparticles greatly enhance immune system production of these antibodies
More general terms
References
- ↑ Bu W, Joyce MG, Nguyen H et al. Immunization with components of the viral fusion apparatus elicits antibodies that neutralize Epstein-Barr virus in B cells and epithelial cells. Immunity 2019 Apr 4; 50:1 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30979688 https://www.cell.com/immunity/fulltext/S1074-7613(19)30127-X